2m 2m 2m 2m 2m 2m 2m
AQUESTIVE THERP (AQST)
NASDAQ
$4.65-$0.01 (-0.24%)
Price as of Aug 21, 2026 7:57 PM EDT- $584.9MMarket Cap
- 17.09%1-Year Change
- Drug Manufacturers - Specialty & GenericIndustry
AQUESTIVE THERP (AQST)
$4.65-$0.01 (-0.24%)
AQST | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $4.66 | ||
Change | +$0.17 (+3.67%) | ||
Open | $4.54 | ||
High | $4.72 | ||
Low | $4.52 | ||
Previous Close | $4.50 | ||
Volume | 2,015,907 | ||
30-Day Average Volume | 3,473,490 | ||
1-Week Change | 9.65% | ||
1-Month Change | 15.35% | ||
1-Year Change | 17.09% | ||
3-Year Change | 163.28% | ||
5-Year Change | 27.67% | ||
Fundamentals | |||
Shares Outstanding | 125.5M | ||
Total Assets | $132.1M | ||
Market Cap | $584.9M | ||
Enterprise Value | $537.1M | ||
Period: QTR TTM FY | |||
Revenue | $13.8M | ||
Net Income | -$22.9M | ||
Free Cash Flow | -$9.7M | ||
EBIT | -$22.9M | ||
EBITDA | -$22.7M | ||
Net Working Capital | $102.0M | ||
EPS | -$0.18 | ||
Enterprise Value/EBITDA | -24 | ||
Enterprise Value/Revenue | 39 | ||
P/B | -10 | ||
P/E | -26 | ||
PEG | 0 | ||
Price/Free Cash Flow | -61 | ||
Price/Operating Cash Flow | -62 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue